Last reviewed · How we verify
Phloroglucin
At a glance
| Generic name | Phloroglucin |
|---|---|
| Also known as | Flospan |
| Sponsor | Ajou University School of Medicine |
| Target | Beta-secretase 1 |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Phloroglucinol Effectiveness on Shortening the Duration of Active Phase of Labor (NA)
- The Efficiency of Acupuncture Combined Intradermal Sterile Water Application in Acute Renal Colic (NA)
- Efficacy of Double Contrast-enhanced Ultrasound of Pelvic in Preoperative Evaluation of Deep Endometriosis
- Effect of Oral Phloroglucin (Flospan®) as Premedication of Non-sedative Diagnostic Esophagogastroduodenoscopy (PHASE3)
- Evaluation of the Efficacy of Tamsulosin (Alpha Blockers) Compared to Phloroglucinol in Improving JJ Ureteral Stent Tolerance. A Randomized Controlled Trial (PHASE3)
- Usefulness Of Flospan As A Premedication For Colonoscopy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Phloroglucin CI brief — competitive landscape report
- Phloroglucin updates RSS · CI watch RSS
- Ajou University School of Medicine portfolio CI